2007
DOI: 10.1021/op700107h
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Scalable Process for DG-041, a Potent EP3 Receptor Antagonist, via Tandem Heck Reactions

Abstract: DG-041 is a small molecule antagonist of the EP3 receptor for prostaglandin E2 that is in clinical development for treatment of peripheral artery disease (PAD). Originally produced using a six-step synthetic procedure, process optimization led to development of a four-step sequence that is readily scalable. The key step in the optimized sequence contains two sequential Heck reactions, involving an intramolecular Heck cyclization followed by an intermolecular Heck coupling, performed in one pot to produce a hig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(20 citation statements)
references
References 8 publications
(8 reference statements)
1
19
0
Order By: Relevance
“…1) revealed to be difficult. 92 7-Halo-3-indolecarbaldehyde (23) prepared by the BIS and Vilsmeier-Haack sequence is also the starting material for many biologically interesting products. For instance, it served as the key building block for the synthesis of a series of monohalide mercaptoacrylic acid derivatives, which were employed in a study View Article Online of SAR on the efficacy of these molecules for inhibition of Ca 2+ -activation of calpain-1 (Scheme 15).…”
Section: Syntheses From 7-haloindolesmentioning
confidence: 99%
“…1) revealed to be difficult. 92 7-Halo-3-indolecarbaldehyde (23) prepared by the BIS and Vilsmeier-Haack sequence is also the starting material for many biologically interesting products. For instance, it served as the key building block for the synthesis of a series of monohalide mercaptoacrylic acid derivatives, which were employed in a study View Article Online of SAR on the efficacy of these molecules for inhibition of Ca 2+ -activation of calpain-1 (Scheme 15).…”
Section: Syntheses From 7-haloindolesmentioning
confidence: 99%
“…To evaluate the peripheral role of EP 3 receptors in bladder afferent functions, a peripherally limited EP 3 receptor antagonist, (2E)-3-{1-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-1H-indol-7-yl}-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041; see Ref. 44), was tested on the micturition reflex in a bladder rhythmic contraction model and on bladder pain sensation by measurement of visceromotor reflex (VMR) and cardiovascular (pressor) responses to noxious urinary bladder distension (UBD).…”
mentioning
confidence: 99%
“…A selection of these reactions is shown in Table 4 [31][32][33][34][35][36][37][38]. A selection of these reactions is shown in Table 4 [31][32][33][34][35][36][37][38].…”
Section: Scheme 2 Gilmore Application Of the Bartoli Indole Synthesismentioning
confidence: 99%